港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

科濟藥業-B

16.600

-0.280-1.66%

成交量：270.50萬

成交額：4,415.87萬

市值：95.12億

市盈率：-10.64

高：16.860

開：16.860

低：15.800

收：16.880

資料載入中...

總覽公司新聞資訊公告

科濟藥業-B盤中異動股價大漲5.10%

年度盤點｜2024年的港股醫藥生物公司跌多漲少，漲跌幅最大前十公司分別有何共性

全球首款CLDN18.2靶向藥國內獲批上市，熱門靶點競爭格局幾何

科濟藥業(02171.HK)自研產品KJC2219啓動中國臨牀試驗

阿斯达克财经

異動解讀 | 科濟藥業CAR-T細胞療法取得重大進展,股價盤中大漲5.98%

科濟藥業-B盤中異動早盤大幅拉昇5.09%報9.490港元

金十數據整理：每日港股市場要聞速遞（12月31日週二）

科濟藥業宣佈啓動一項通用型CD19/CD20 CAR-T研究者發起的臨牀試驗

國家醫保局召開集採座談會，科濟藥業關鍵Ⅱ期臨牀獲得成功丨醫藥早參

每日经济新闻

CAR-T療法在實體腫瘤領域獲重大進展，科濟藥業盤中漲超20%

醫療保健板塊向好科濟藥業升逾18% 機構指25年有望進入新一輪增長週期

【港股異動 | 科濟藥業-B(02171.HK)漲幅擴大逾20%】科濟藥業-B(02171.HK)午後漲幅擴大逾20%，截至發稿，漲21.33%，報10.18港元，成交額1.18億港元。

港股異動 | 科濟藥業-B(02171)漲幅擴大逾20% Claudin18.2 CAR-T治療胃癌關鍵II期臨牀試驗取得初步陽性結果

科濟藥業－Ｂ(02171)股價大幅上升20.62%，現價港幣$10.12

阿斯达克财经

異動解讀 | 科濟藥業-B (02171)大漲5.01% 旗艦產品臨牀試驗取得陽性結果

科濟藥業-B盤中異動快速上漲5.01%

科濟藥業-B現漲超4% 關鍵II期臨牀試驗CT041-ST-01已取得陽性結果

科濟藥業關鍵II期臨牀試驗取得初步陽性結果

科濟藥業宣佈Claudin18.2 CAR-T舒瑞基奧侖賽注射液中國胃癌關鍵II期臨牀試驗取得初步陽性結果

科濟藥業(02171.HK)舒瑞基奧侖賽注射液臨牀試驗表明安全性可控

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02171/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02171","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02171\",,,,,undefined,":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"科濟藥業-B","latestPrice":16.6,"timestamp":1747037292027,"preClose":16.88,"halted":0,"volume":2705000,"delay":0,"floatShares":573000000,"shares":573000000,"eps":-1.5597736683342687,"marketStatus":"已收盤","change":-0.28,"latestTime":"05-12 16:08:12","open":16.86,"high":16.86,"low":15.8,"amount":44158700,"amplitude":0.062796,"askPrice":16.62,"askSize":9000,"bidPrice":16.6,"bidSize":55000,"shortable":3,"etf":0,"ttmEps":-1.5597736683342687,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747099800000},"marketStatusCode":5,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":16.88,"openAndCloseTimeList":[[1747013400000,1747022400000],[1747026000000,1747036800000]],"volumeRatio":1.144538,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02171\",,,,,undefined,":{"symbol":"02171","floatShares":573000000,"roa":"-23.91%","roe":"-55.84%","lyrEps":-1.559774,"volumeRatio":1.144538,"shares":573000000,"dividePrice":0,"high":16.86,"amplitude":0.062796,"preClose":16.88,"low":15.8,"week52Low":2.48,"pbRate":"8.33","psRate":"223.29","week52High":19.78,"institutionHeld":0,"latestPrice":16.6,"committee":0.71875,"eps":-1.5597736683342687,"divideRate":0,"volume":2705000,"delay":0,"ttmEps":-1.5597736683342687,"open":16.86,"prevYearClose":9.21,"prevWeekClose":16.88,"prevMonthClose":15.54,"prevQuarterClose":15.46,"fiveDayClose":15.94,"twentyDayClose":11.16,"sixtyDayClose":9.66},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02171\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2500915649","title":"科濟藥業-B盤中異動 股價大漲5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500915649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500915649?lang=zh_tw&edition=fundamental","pubTime":"2025-01-02 15:40","pubTimestamp":1735803613,"startTime":"0","endTime":"0","summary":"2025年01月02日临近收盘15时40分，科济药业-B股票出现波动，股价大幅上涨5.10%。科济药业-B股票所在的生物技术行业中，整体跌幅为0.98%。消息层面，截至15时40分，《国家医保局召开集采座谈会，科济药业关键Ⅱ期临床获得成功丨医药早参》资讯为影响科济药业-B的重要信息。此次胃癌关键二期临床获得成功，科济药业预计将于2025年上半年递交上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010215401495f62d8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010215401495f62d8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1585","BK1574","02171","BK1587"],"gpt_icon":0},{"id":"2500988151","title":"年度盤點｜2024年的港股醫藥生物公司跌多漲少，漲跌幅最大前十公司分別有何共性","url":"https://stock-news.laohu8.com/highlight/detail?id=2500988151","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500988151?lang=zh_tw&edition=fundamental","pubTime":"2025-01-01 18:21","pubTimestamp":1735726876,"startTime":"0","endTime":"0","summary":"刚刚过去的2024年，港股医药生物市场中的106只个股，股价（后复权）累计实现上涨的有26只，占比约25%。这里的医药生物市场，囊括了化学制药、中药、生物制品、医药商业、医疗器械、医疗服务这些细分市场。从涨幅最大或者跌幅最大的前十只个股来看，均以18A药企（港交所18A规则上市的公司）为主。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202501013284563250.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501013284563250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02171","06996","01541","03933","01681","BK1161","09886","LU0348783233.USD","LU2488822045.USD","IE00B5MMRT66.SGD","LU1794554557.SGD","BK1515","02407","09926","02257","09939","BK1189","02415","BK1100","06990","HSTECH","HSCEI","LU0196878994.USD","LU1720050803.USD","LU2328871848.SGD","02877","YANG","BK1585","06998","IE00BPRC5H50.USD","BK1606","07226","BK1247","BK1142","BK1587","BK1583","LU0417516571.SGD","01952","06855","09877","01167","09995","BK1191","06185","IE00B543WZ88.USD","BK1574","LU1969619763.USD","02511","LU0348784397.USD"],"gpt_icon":0},{"id":"2500612310","title":"全球首款CLDN18.2靶向藥國內獲批上市，熱門靶點競爭格局幾何","url":"https://stock-news.laohu8.com/highlight/detail?id=2500612310","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500612310?lang=zh_tw&edition=fundamental","pubTime":"2025-01-01 00:02","pubTimestamp":1735660967,"startTime":"0","endTime":"0","summary":"12月31日，国家药品监督管理局官网显示，安斯泰来申报的进口新药注射用佐妥昔单抗（商品名：威络益）上市，用于局部晚期不可切除或转移性胃或胃食管交界处（GEJ）腺癌患者的一线治疗。佐妥昔单抗是一款靶向治疗药物，为安斯泰来自主研发的全球首款CLDN18.2的IgG1单抗。该药物通过特异性结合CLDN18.2，增强免疫系统对肿瘤细胞的识别和攻击，从而抑制肿瘤生长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202501013284293845.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501013284293845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","LU0196878994.USD","BK1585","01801","06628","BK1583","BK1589","LU2328871848.SGD","LU2488822045.USD","BK1587","LU1969619763.USD","02171","BK1161","06990"],"gpt_icon":0},{"id":"2495563588","title":"科濟藥業(02171.HK)自研產品KJC2219啓動中國臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2495563588","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495563588?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 11:05","pubTimestamp":1735614300,"startTime":"0","endTime":"0","summary":"科济药业-B(02171.HK) 宣布，公司自主研发、针对CD19/CD20双标靶的通用型CAR-T细胞治疗候选产品KJ-C2219，已在中国启动一项针对复发陂难治性B细胞非何杰金氏淋巴瘤研究者发起的临床试验。KJ-C2219基于THANK-u Plus平台开发，计划用于治疗血液恶性肿瘤和自体免疫疾病。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-30 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211223145801705_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211223145801705_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1407031/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","BK1587","BK1585","02171","BK1574","03347","BK1576","BK1583","BK1161"],"gpt_icon":0},{"id":"1115272861","title":"異動解讀 | 科濟藥業CAR-T細胞療法取得重大進展,股價盤中大漲5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115272861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115272861?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 09:36","pubTimestamp":1735609004,"startTime":"0","endTime":"0","summary":"科济药业今日盘中股价大涨5.98%,引发市场关注。这主要得益于公司在CAR-T细胞疗法领域取得多项重大进展。这些进展标志着科济药业的CAR-T细胞疗法技术已取得重要突破,不仅能用于治疗血液系统癌症,也有望扩展至实体瘤领域。公司CAR-T产品进展充分展示了其在这一尖端抗癌疗法领域的领先地位,也增强了市场对科济药业长期增长潜力的看好预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 科济药业CAR-T细胞疗法取得重大进展,股价盘中大涨5.98%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02171"],"gpt_icon":0},{"id":"2495516684","title":"科濟藥業-B盤中異動 早盤大幅拉昇5.09%報9.490港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495516684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495516684?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 09:34","pubTimestamp":1735608863,"startTime":"0","endTime":"0","summary":"2024年12月31日早盘09时34分，科济药业-B股票出现波动，股价急速拉升5.09%。截至发稿，该股报9.490港元/股，成交量115.55万股，换手率0.20%，振幅5.87%。科济药业-B股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，宜明昂科-B、科笛-B、科济药业-B涨幅较大，振幅较大的相关个股有宜明昂科-B、科笛-B、科济药业-B，振幅分别为10.21%、6.43%、5.87%。此次胃癌关键二期临床获得成功，科济药业预计将于2025年上半年递交上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123109342395f3524b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123109342395f3524b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02171","BK1585"],"gpt_icon":0},{"id":"2495893866","title":"金十數據整理：每日港股市場要聞速遞（12月31日 週二）","url":"https://stock-news.laohu8.com/highlight/detail?id=2495893866","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495893866?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 09:09","pubTimestamp":1735607363,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["01931","01093","BK4134","02324","LU1226288253.USD","BK0006","BK0201","01766","BK1515","BK0002","LU0326950275.SGD","BK0010","HSCEI","09939","01918","BK1188","601238","LU0072913022.USD","07226","IE0008369823.USD","BK4503","IE0008368742.USD","BK1191","02238","BK1565","BK1574","IE00B031HY20.USD","BK1141","HSTECH","SG9999004220.SGD","III","03660","02171","QFIN","PR","YANG","BK4531","BK0175","BK0028","BK1240","BK0279","161631","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","601766","03347","BK4588","BK4213","LU1951186391.HKD"],"gpt_icon":0},{"id":"2495868661","title":"科濟藥業宣佈啓動一項通用型CD19/CD20 CAR-T研究者發起的臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2495868661","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495868661?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 08:30","pubTimestamp":1735605000,"startTime":"0","endTime":"0","summary":"上海2024年12月31日 /美通社/ -- 科济药业，一家主要专注于治疗血液恶性肿瘤和实体瘤的创新CAR-T细胞疗法公司宣布，公司自主研发的一款靶向CD19/CD20的通用型CAR-T细胞治疗候选产品KJ-C2219已在中国启动一项针对复发/难治性B细胞非霍奇金淋巴瘤的研究者发起的临床试验。在此平台下的同种异体BCMA或CD19/CD20双靶CAR-T在NK存在时都显示出极强的抗肿瘤疗效，表明该平台可广泛用于多种通用型CAR-T细胞的研制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4586929_ZH86929_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1574","BK1585","BK4230","BK1587","CAR","02171","BK4022","BK1161"],"gpt_icon":0},{"id":"2495889306","title":"國家醫保局召開集採座談會，科濟藥業關鍵Ⅱ期臨牀獲得成功丨醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2495889306","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495889306?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 07:49","pubTimestamp":1735602597,"startTime":"0","endTime":"0","summary":"NO.3CAR-T治疗实体瘤获重大进展，科济药业关键Ⅱ期临床获得成功12月30日，科济药业宣布，其Claudin 18.2自体CAR-T细胞候选产品舒瑞基奥仑赛注射液的关键Ⅱ期临床试验CT041-ST-01（NCT04已取得阳性结果。此次胃癌关键二期临床获得成功，科济药业预计将于2025年上半年递交上市申请。同时，公司后续将积极参与国家药品集采工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231075024a20fa189&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231075024a20fa189&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","02171","BK1515","09939","BK1161","BK1587","BK1574"],"gpt_icon":0},{"id":"2495183375","title":"CAR-T療法在實體腫瘤領域獲重大進展，科濟藥業盤中漲超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495183375","media":"第一财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495183375?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 16:49","pubTimestamp":1735548576,"startTime":"0","endTime":"0","summary":"12月30日早间，科济药业（02171.HK）宣布，舒瑞基奥仑赛注射液用于治疗晚期胃/食管胃结合部腺癌的中国关键II期临床试验取得初步阳性结果。消息公布后，科济药业当日股价盘中大涨超20%，当日收盘时报9.03港元/股，涨7.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412303282800620.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412303282800620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1587","BK1161","BK4230","CAR","BK1574","BK4022","02171","BK1585"],"gpt_icon":0},{"id":"2495593699","title":"醫療保健板塊向好 科濟藥業升逾18% 機構指25年有望進入新一輪增長週期","url":"https://stock-news.laohu8.com/highlight/detail?id=2495593699","media":"金吾资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495593699?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 14:10","pubTimestamp":1735539023,"startTime":"0","endTime":"0","summary":"目前，行业正经历较为剧烈的供给侧结构性改革，药品及器械集采亦接近尾声，25年有望进入新一轮增长周期。在地缘政治扰动之下，国家有望加大对于自主可控的支持力度，建议优先配置创新药、创新器械、医疗设备等细分行业，同时建议关注AI医疗、并购重组等带来的主题投资机会。近期多项创新器械陆续获批，商保有望为创新产品放量打开新空间，国内AI医疗发展迅速、海外和国内脑机接口技术进展有望持续催化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123014103995f234d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123014103995f234d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02171","BK1585"],"gpt_icon":0},{"id":"2495598190","title":"【港股異動 | 科濟藥業-B(02171.HK)漲幅擴大逾20%】科濟藥業-B(02171.HK)午後漲幅擴大逾20%，截至發稿，漲21.33%，報10.18港元，成交額1.18億港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2495598190","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495598190?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 14:03","pubTimestamp":1735538588,"startTime":"0","endTime":"0","summary":"科济药业-B(02171.HK)午后涨幅扩大逾20%，截至发稿，涨21.33%，报10.18港元，成交额1.18亿港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/30140346931117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1587","BK1585","BK1574","02171"],"gpt_icon":0},{"id":"2495985405","title":"港股異動 | 科濟藥業-B(02171)漲幅擴大逾20% Claudin18.2 CAR-T治療胃癌關鍵II期臨牀試驗取得初步陽性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2495985405","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495985405?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 13:51","pubTimestamp":1735537916,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科济药业-B午后涨幅扩大逾20%，截至发稿，涨21.33%，报10.18港元，成交额1.18亿港元。消息面上，12月30日，科济药业宣布，关键II期临床试验CT041-ST-01已取得阳性结果。既往试验数据表明，该产品安全性可控。科济药业创始人李宗海博士表示，预计将于2025年上半年向NMPA递交新药上市申请，期待舒瑞基奥仑赛能成为全球首款针对实体瘤的CAR-T产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1230711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK4230","BK1576","02171","CAR","BK1161","BK1574","BK1585","03347","BK1583","BK4022","BK1141"],"gpt_icon":0},{"id":"2495859816","title":"科濟藥業－Ｂ(02171)股價大幅上升20.62%，現價港幣$10.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2495859816","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495859816?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 13:48","pubTimestamp":1735537680,"startTime":"0","endTime":"0","summary":"[上升股]科济药业－Ｂ(02171) 股价在下午01:48比前收市价大幅上升20.62%，现股价为港币$10.12。至目前为止，今日最高价为$10.12，而最低价为$8.42。总成交量为1.23千万股，总成交金额为港币$1.136亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241230880/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1587","BK1161","02171","BK1585","BK1574"],"gpt_icon":0},{"id":"1172190099","title":"異動解讀 | 科濟藥業-B (02171)大漲5.01% 旗艦產品臨牀試驗取得陽性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1172190099","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172190099?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 09:42","pubTimestamp":1735522964,"startTime":"0","endTime":"0","summary":"科济药业-B今日盘中大涨5.01%,引发市场高度关注。公司旗舰产品舒瑞基奥仑赛注射液是一种靶向Claudin18.2蛋白的自体CAR-T细胞疗法,近期在中国进行的一项关键II期临床试验CT041-ST-01取得阳性结果。临床数据也表明该产品总体安全性可控。舒瑞基奥仑赛注射液作为一种潜在全球首创的CAR-T产品,临床阳性结果引发市场对科济药业未来发展前景的乐观预期。目前该产品还在多个临床阶段,未来如果能顺利上市,必将助力公司业绩实现新的增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 科济药业-B (02171)大涨5.01% 旗舰产品临床试验取得阳性结果","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02171"],"gpt_icon":0},{"id":"2495550537","title":"科濟藥業-B盤中異動 快速上漲5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495550537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495550537?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 09:40","pubTimestamp":1735522840,"startTime":"0","endTime":"0","summary":"2024年12月30日早盘09时40分，科济药业-B股票出现异动，股价快速上涨5.01%。截至发稿，该股报8.810港元/股，成交量76.45万股，换手率0.13%，振幅5.13%。科济药业-B股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，康希诺生物、华康生物医学、科济药业-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、华康生物医学、康希诺生物，振幅分别为9.19%、6.67%、6.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123009404095f1ea2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123009404095f1ea2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02171","BK1585","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2495557910","title":"科濟藥業-B現漲超4% 關鍵II期臨牀試驗CT041-ST-01已取得陽性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2495557910","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495557910?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 09:38","pubTimestamp":1735522680,"startTime":"0","endTime":"0","summary":"　　科济药业-B早盘上涨4.05%，现报8.73港元，成交额492.07万港元。　　科济药业-B公布，关键II期临床试验CT041-ST-01已取得阳性结果。该试验是一项在中国进行的随机对照、多中心的临床试验，旨在评估舒瑞基奥仑赛注射液治疗Claudin18.2表达阳性、既往接受过至少2线治疗失败的晚期胃╱食管胃结合部腺癌的有效性和安全性，受试者以2：1的比例随机分配至舒瑞基奥仑赛注射液组或研究者选择治疗组。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-12-30/doc-ineceyez4733913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03347","BK1161","BK1585","BK1574","BK1583","02171","BK1587","BK1576","BK1141"],"gpt_icon":0},{"id":"2495655284","title":"科濟藥業關鍵II期臨牀試驗取得初步陽性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2495655284","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495655284?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 09:05","pubTimestamp":1735520740,"startTime":"0","endTime":"0","summary":"财中社12月30日电科济药业-B（02171）发布自愿公告，宣布其关键II期临床试验CT041-ST-01(NCT04581473)取得初步阳性结果。该试验旨在评估舒瑞基奥仑赛注射液治疗Claudin18.2表达阳性的晚期胃/食管胃结合部腺癌的有效性和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412303282144921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02171","BK1587","BK1576","BK1585","03347","BK1161","BK1583","BK1574","BK1141"],"gpt_icon":0},{"id":"2495756279","title":"科濟藥業宣佈Claudin18.2 CAR-T舒瑞基奧侖賽注射液中國胃癌關鍵II期臨牀試驗取得初步陽性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2495756279","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495756279?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 08:30","pubTimestamp":1735518600,"startTime":"0","endTime":"0","summary":"上海2024年12月30日 /美通社/ --2024年12月30日，科济药业，一家主要专注于治疗血液恶性肿瘤和实体瘤的创新CAR-T细胞疗法公司宣布，关键II期临床试验CT041-ST-01已取得阳性结果。\" 关于舒瑞基奥仑赛注射液 舒瑞基奥仑赛注射液是一种潜在全球同类首创的、靶向Claudin18.2蛋白的自体CAR-T细胞候选产品，用于治疗Claudin18.2阳性实体瘤，主要治疗胃癌/食管胃结合部腺癌及胰腺癌。2020年，舒瑞基奥仑赛注射液被美国FDA授予\"孤儿药\"认定用于治疗胃癌/食管胃结合部腺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4586717_ZH86717_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["CAR","BK4230","BK1161","BK1585","02171","BK4022","BK1587","BK1574"],"gpt_icon":0},{"id":"2495559165","title":"科濟藥業(02171.HK)舒瑞基奧侖賽注射液臨牀試驗表明安全性可控","url":"https://stock-news.laohu8.com/highlight/detail?id=2495559165","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495559165?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 08:21","pubTimestamp":1735518060,"startTime":"0","endTime":"0","summary":"科济药业公布，关键II期临床试验CT041-ST-01已取得阳性结果。该试验主要终点已达成，即与研究者选择治疗组相比，舒瑞基奥仑赛注射液组中的受试者的无进展生存期具有统计学意义上的显著改善。既往试验数据表明，该产品安全性可控。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211223145801705_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211223145801705_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1406645/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","BK1585","BK1161","BK1587","03347","BK1141","BK1583","02171","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02171\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2025-03-18","symbol":"02171","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1742227200000,"reportTimeType":"","actualEps":null},{"date":"2024-08-28","symbol":"02171","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"盤後","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-26","symbol":"02171","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null},{"date":"2023-08-22","symbol":"02171","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692667800000,"name":null,"time":"","dateTimestamp":1692633600000,"actualEps":null},{"date":"2023-03-21","symbol":"02171","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1679362200000,"name":null,"time":"","dateTimestamp":1679328000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02171\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02171\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":1,"strongSell":0,"meanLabel":"SELL","meanPercent":1,"analysts":1,"updateTime":1738771200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02171\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02171","date":"2025-05-09","current":-10.836143,"percent":0.118325,"low":-15.575744,"twenty":-9.469219,"median":-4.996395,"eighty":-2.5913,"high":-0.95958,"avg":-5.782333,"sd":3.597005,"marketCap":9290683315},"quantilePoints":[{"date":"2021-06-18","current":-13.296641,"twenty":-14.480215,"median":-14.415234,"eighty":-13.744078,"marketCap":17020400880},{"date":"2021-06-25","current":-14.103316,"twenty":-14.433431,"median":-14.120327,"eighty":-13.139055,"marketCap":18041624932},{"date":"2021-07-02","current":-13.483801,"twenty":-14.359655,"median":-13.987785,"eighty":-13.334073,"marketCap":17218972223},{"date":"2021-07-09","current":-14.564659,"twenty":-14.401025,"median":-13.915878,"eighty":-13.47657,"marketCap":18580604294},{"date":"2021-07-16","current":-13.475367,"twenty":-14.401025,"median":-14.081504,"eighty":-13.477054,"marketCap":17190604888},{"date":"2021-07-23","current":-13.409947,"twenty":-14.344062,"median":-13.826345,"eighty":-13.474883,"marketCap":17105502884},{"date":"2021-07-30","current":-12.788772,"twenty":-14.317545,"median":-13.553323,"eighty":-13.086527,"marketCap":16367952179},{"date":"2021-08-06","current":-11.842141,"twenty":-14.198244,"median":-13.484784,"eighty":-12.837817,"marketCap":15119789448},{"date":"2021-08-13","current":-15.575744,"twenty":-14.344062,"median":-13.505234,"eighty":-12.971066,"marketCap":19913869029},{"date":"2021-08-20","current":-13.617443,"twenty":-14.404773,"median":-13.617443,"eighty":-13.043173,"marketCap":17360808897},{"date":"2021-08-27","current":-3.504357,"twenty":-14.35918,"median":-13.505234,"eighty":-12.464271,"marketCap":20736521738},{"date":"2021-09-03","current":-4.6578,"twenty":-14.344062,"median":-13.483801,"eighty":-10.967699,"marketCap":27573049425},{"date":"2021-09-10","current":-4.110528,"twenty":-14.328504,"median":-13.442355,"eighty":-4.263773,"marketCap":24395907928},{"date":"2021-09-17","current":-4.50623,"twenty":-14.257307,"median":-13.296641,"eighty":-4.151025,"marketCap":26665294712},{"date":"2021-09-24","current":-4.556854,"twenty":-14.213471,"median":-13.240145,"eighty":-4.151247,"marketCap":26977335394},{"date":"2021-09-30","current":-5.205472,"twenty":-14.152565,"median":-13.033998,"eighty":-4.238734,"marketCap":30920394932},{"date":"2021-10-08","current":-4.274413,"twenty":-14.1254,"median":-12.746107,"eighty":-4.267672,"marketCap":25388764646},{"date":"2021-10-15","current":-4.004217,"twenty":-14.110956,"median":-12.40317,"eighty":-4.217063,"marketCap":23800193897},{"date":"2021-10-22","current":-4.042014,"twenty":-14.077142,"median":-11.842141,"eighty":-4.146115,"marketCap":24197336584},{"date":"2021-10-29","current":-3.995029,"twenty":-13.988568,"median":-7.719133,"eighty":-4.043027,"marketCap":23856928566},{"date":"2021-11-05","current":-3.490492,"twenty":-13.925987,"median":-4.848164,"eighty":-3.978881,"marketCap":20878358412},{"date":"2021-11-12","current":-4.109048,"twenty":-13.862158,"median":-4.772452,"eighty":-3.912909,"marketCap":24679581276},{"date":"2021-11-19","current":-4.398655,"twenty":-13.789344,"median":-4.652795,"eighty":-3.938397,"marketCap":26381621364},{"date":"2021-11-26","current":-3.881872,"twenty":-13.676336,"median":-4.461584,"eighty":-3.912909,"marketCap":23289581870},{"date":"2021-12-03","current":-3.780317,"twenty":-13.60454,"median":-4.407722,"eighty":-3.88002,"marketCap":22722235174},{"date":"2021-12-10","current":-3.872814,"twenty":-13.544799,"median":-4.373965,"eighty":-3.86241,"marketCap":23317949205},{"date":"2021-12-17","current":-3.625614,"twenty":-13.504139,"median":-4.27644,"eighty":-3.842315,"marketCap":21814480461},{"date":"2021-12-24","current":-2.910912,"twenty":-13.490775,"median":-4.265022,"eighty":-3.812246,"marketCap":17531012906},{"date":"2021-12-31","current":-2.585862,"twenty":-13.484391,"median":-4.247891,"eighty":-3.79337,"marketCap":15607269865},{"date":"2022-01-07","current":-2.232317,"twenty":-2.553006,"median":-2.430006,"eighty":-2.271168,"marketCap":13422252083},{"date":"2022-01-14","current":-2.293395,"twenty":-2.516293,"median":-2.440198,"eighty":-2.284514,"marketCap":13819528044},{"date":"2022-01-21","current":-1.973359,"twenty":-2.503055,"median":-2.379192,"eighty":-2.244424,"marketCap":11918278806},{"date":"2022-01-28","current":-1.567653,"twenty":-2.497826,"median":-2.282294,"eighty":-1.912458,"marketCap":9443817111},{"date":"2022-02-04","current":-1.597023,"twenty":-2.495835,"median":-2.271161,"eighty":-1.7445,"marketCap":9616028284},{"date":"2022-02-11","current":-1.527944,"twenty":-2.450389,"median":-2.232317,"eighty":-1.597023,"marketCap":9218671744},{"date":"2022-02-18","current":-1.640317,"twenty":-2.430006,"median":-1.957226,"eighty":-1.567653,"marketCap":9945266561},{"date":"2022-02-25","current":-1.752093,"twenty":-2.403518,"median":-1.752093,"eighty":-1.58606,"marketCap":10649155290},{"date":"2022-03-04","current":-1.721528,"twenty":-2.379192,"median":-1.802303,"eighty":-1.597023,"marketCap":10467392744},{"date":"2022-03-11","current":-1.27859,"twenty":-2.319774,"median":-1.7445,"eighty":-1.563041,"marketCap":7762463892},{"date":"2022-03-18","current":-1.343853,"twenty":-2.293395,"median":-1.710725,"eighty":-1.527944,"marketCap":8126151805},{"date":"2022-03-25","current":-1.48424,"twenty":-2.271193,"median":-1.66812,"eighty":-1.45262,"marketCap":8660318427},{"date":"2022-04-01","current":-1.382568,"twenty":-2.27113,"median":-1.625557,"eighty":-1.446309,"marketCap":8076671724},{"date":"2022-04-08","current":-1.446292,"twenty":-2.256223,"median":-1.603004,"eighty":-1.430534,"marketCap":8452595796},{"date":"2022-04-14","current":-1.315924,"twenty":-2.240389,"median":-1.599031,"eighty":-1.412577,"marketCap":7677964375},{"date":"2022-04-22","current":-1.166567,"twenty":-2.204172,"median":-1.58853,"eighty":-1.380244,"marketCap":6800808208},{"date":"2022-04-29","current":-1.03074,"twenty":-2.086516,"median":-1.563041,"eighty":-1.344275,"marketCap":5912260402},{"date":"2022-05-06","current":-1.048279,"twenty":-1.966906,"median":-1.532481,"eighty":-1.31332,"marketCap":5962912284},{"date":"2022-05-13","current":-1.095949,"twenty":-1.941092,"median":-1.527944,"eighty":-1.237924,"marketCap":6122531351},{"date":"2022-05-20","current":-1.1311,"twenty":-1.913082,"median":-1.491391,"eighty":-1.121103,"marketCap":6407565399},{"date":"2022-05-27","current":-1.122011,"twenty":-1.869508,"median":-1.469686,"eighty":-1.116891,"marketCap":6350558589},{"date":"2022-06-02","current":-1.110067,"twenty":-1.859596,"median":-1.45262,"eighty":-1.107798,"marketCap":6316675923},{"date":"2022-06-10","current":-1.242652,"twenty":-1.832277,"median":-1.441,"eighty":-1.109672,"marketCap":7023596333},{"date":"2022-06-17","current":-1.231899,"twenty":-1.788045,"median":-1.419625,"eighty":-1.110242,"marketCap":6955184681},{"date":"2022-06-24","current":-1.63937,"twenty":-1.757382,"median":-1.412127,"eighty":-1.11557,"marketCap":9292582811},{"date":"2022-06-30","current":-1.473408,"twenty":-1.747537,"median":-1.426443,"eighty":-1.117703,"marketCap":8337460134},{"date":"2022-07-08","current":-1.759827,"twenty":-1.772247,"median":-1.446292,"eighty":-1.11996,"marketCap":9968454388},{"date":"2022-07-15","current":-1.593377,"twenty":-1.768784,"median":-1.453067,"eighty":-1.121648,"marketCap":8941954508},{"date":"2022-07-22","current":-1.624828,"twenty":-1.763117,"median":-1.473408,"eighty":-1.12261,"marketCap":9124443376},{"date":"2022-07-29","current":-1.519392,"twenty":-1.755187,"median":-1.491391,"eighty":-1.127864,"marketCap":8542760110},{"date":"2022-08-05","current":-1.607124,"twenty":-1.747537,"median":-1.48424,"eighty":-1.145835,"marketCap":9013017933},{"date":"2022-08-12","current":-1.820283,"twenty":-1.755187,"median":-1.502802,"eighty":-1.160425,"marketCap":10222359580},{"date":"2022-08-19","current":-1.863313,"twenty":-1.782747,"median":-1.509519,"eighty":-1.165381,"marketCap":10359266181},{"date":"2022-08-26","current":-14.08994,"twenty":-1.828619,"median":-1.528134,"eighty":-1.181468,"marketCap":11694105546},{"date":"2022-09-02","current":-12.116182,"twenty":-1.859596,"median":-1.541739,"eighty":-1.20133,"marketCap":10019857778},{"date":"2022-09-09","current":-11.151252,"twenty":-1.91395,"median":-1.55979,"eighty":-1.211188,"marketCap":9186771653},{"date":"2022-09-16","current":-9.857086,"twenty":-1.984158,"median":-1.568909,"eighty":-1.216087,"marketCap":8045557783},{"date":"2022-09-23","current":-7.883202,"twenty":-2.263676,"median":-1.576689,"eighty":-1.224656,"marketCap":6310912701},{"date":"2022-09-30","current":-7.911041,"twenty":-2.355425,"median":-1.58489,"eighty":-1.231568,"marketCap":6345297469},{"date":"2022-10-07","current":-8.011101,"twenty":-2.446312,"median":-1.58858,"eighty":-1.233104,"marketCap":6425184307},{"date":"2022-10-14","current":-7.938783,"twenty":-2.526166,"median":-1.597023,"eighty":-1.238099,"marketCap":6299647847},{"date":"2022-10-21","current":-9.832614,"twenty":-6.942728,"median":-1.601309,"eighty":-1.239569,"marketCap":7749023348},{"date":"2022-10-28","current":-9.370789,"twenty":-7.773405,"median":-1.60443,"eighty":-1.244895,"marketCap":7372413965},{"date":"2022-11-04","current":-10.185604,"twenty":-7.996637,"median":-1.606458,"eighty":-1.25517,"marketCap":8091443115},{"date":"2022-11-11","current":-9.611502,"twenty":-8.36331,"median":-1.624828,"eighty":-1.264016,"marketCap":7703419045},{"date":"2022-11-18","current":-10.759022,"twenty":-8.806878,"median":-1.639844,"eighty":-1.279234,"marketCap":8593591912},{"date":"2022-11-25","current":-9.37601,"twenty":-9.141589,"median":-1.667958,"eighty":-1.287983,"marketCap":7429519701},{"date":"2022-12-02","current":-9.827805,"twenty":-9.368924,"median":-1.689407,"eighty":-1.31332,"marketCap":7921924171},{"date":"2022-12-09","current":-11.242992,"twenty":-9.562447,"median":-1.703343,"eighty":-1.32151,"marketCap":9146845972},{"date":"2022-12-16","current":-10.648692,"twenty":-9.641357,"median":-1.733014,"eighty":-1.343923,"marketCap":8643139811},{"date":"2022-12-23","current":-10.024984,"twenty":-9.741505,"median":-1.759827,"eighty":-1.344238,"marketCap":8139433650},{"date":"2022-12-30","current":-10.434012,"twenty":-9.817483,"median":-1.768967,"eighty":-1.344348,"marketCap":8574452607},{"date":"2023-01-06","current":-10.966641,"twenty":-9.842403,"median":-1.7838,"eighty":-1.348482,"marketCap":9104741856},{"date":"2023-01-13","current":-13.467972,"twenty":-9.98818,"median":-1.822183,"eighty":-1.35497,"marketCap":11395242952},{"date":"2023-01-20","current":-13.557236,"twenty":-10.173418,"median":-1.8366,"eighty":-1.365012,"marketCap":11372337941},{"date":"2023-01-27","current":-13.820637,"twenty":-10.199052,"median":-1.842332,"eighty":-1.370037,"marketCap":11595661798},{"date":"2023-02-03","current":-13.459803,"twenty":-10.378203,"median":-1.863313,"eighty":-1.370767,"marketCap":11351397072},{"date":"2023-02-10","current":-12.297733,"twenty":-10.466354,"median":-1.893269,"eighty":-1.373224,"marketCap":10309038714},{"date":"2023-02-17","current":-11.24262,"twenty":-10.626066,"median":-1.941092,"eighty":-1.378695,"marketCap":9335407279},{"date":"2023-02-24","current":-11.758835,"twenty":-10.767474,"median":-2.076656,"eighty":-1.382568,"marketCap":9644678441},{"date":"2023-03-03","current":-11.697374,"twenty":-10.840142,"median":-2.252496,"eighty":-1.394713,"marketCap":9656132928},{"date":"2023-03-10","current":-9.995937,"twenty":-10.174886,"median":-10.10778,"eighty":-10.040674,"marketCap":8190698973},{"date":"2023-03-17","current":-10.038612,"twenty":-11.309337,"median":-4.129297,"eighty":-1.557839,"marketCap":8305254204},{"date":"2023-03-24","current":-7.238043,"twenty":-11.300534,"median":-4.15097,"eighty":-1.563963,"marketCap":7434634452},{"date":"2023-03-31","current":-7.136417,"twenty":-11.285782,"median":-4.185168,"eighty":-1.568155,"marketCap":7274257130},{"date":"2023-04-06","current":-7.48964,"twenty":-11.272911,"median":-4.209273,"eighty":-1.569663,"marketCap":7629378344},{"date":"2023-04-14","current":-8.347684,"twenty":-11.261549,"median":-4.247213,"eighty":-1.570497,"marketCap":8511827184},{"date":"2023-04-21","current":-7.227891,"twenty":-11.248529,"median":-4.265022,"eighty":-1.574301,"marketCap":7366224602},{"date":"2023-04-28","current":-6.965007,"twenty":-11.242769,"median":-4.27644,"eighty":-1.577657,"marketCap":7045455879},{"date":"2023-05-05","current":-6.998831,"twenty":-11.223942,"median":-4.349275,"eighty":-1.58047,"marketCap":7091279982},{"date":"2023-05-12","current":-6.648882,"twenty":-11.178055,"median":-4.407495,"eighty":-1.584657,"marketCap":6690319078},{"date":"2023-05-19","current":-6.503974,"twenty":-11.148692,"median":-4.416938,"eighty":-1.5861,"marketCap":6452481216},{"date":"2023-05-25","current":-6.275646,"twenty":-11.143926,"median":-4.556854,"eighty":-1.587127,"marketCap":6200341630},{"date":"2023-06-02","current":-6.296999,"twenty":-11.114578,"median":-4.7039,"eighty":-1.591475,"marketCap":6200341630},{"date":"2023-06-09","current":-6.085036,"twenty":-11.002943,"median":-4.805724,"eighty":-1.594106,"marketCap":5982986890},{"date":"2023-06-16","current":-6.396517,"twenty":-10.96387,"median":-5.172616,"eighty":-1.59766,"marketCap":6259124746},{"date":"2023-06-23","current":-5.864103,"twenty":-10.952784,"median":-5.906495,"eighty":-1.60021,"marketCap":5706849033},{"date":"2023-06-30","current":-5.780429,"twenty":-10.933196,"median":-5.948886,"eighty":-1.601039,"marketCap":5574532977},{"date":"2023-07-07","current":-6.060693,"twenty":-10.906132,"median":-5.977284,"eighty":-1.601578,"marketCap":5833412218},{"date":"2023-07-14","current":-6.02436,"twenty":-10.889225,"median":-5.979717,"eighty":-1.602524,"marketCap":5879807825},{"date":"2023-07-21","current":-6.194623,"twenty":-10.840142,"median":-5.977284,"eighty":-1.60443,"marketCap":6017885504},{"date":"2023-07-28","current":-6.722973,"twenty":-10.819432,"median":-5.998155,"eighty":-1.604617,"marketCap":6524170327},{"date":"2023-08-04","current":-6.617116,"twenty":-10.804403,"median":-6.017966,"eighty":-1.605792,"marketCap":6432118541},{"date":"2023-08-10","current":-6.095496,"twenty":-10.792752,"median":-6.02436,"eighty":-1.606591,"marketCap":5891626475},{"date":"2023-08-18","current":-5.689786,"twenty":-10.774478,"median":-6.017966,"eighty":-1.609327,"marketCap":5460110864},{"date":"2023-08-25","current":-5.594472,"twenty":-10.762403,"median":-5.998155,"eighty":-1.619215,"marketCap":5540660445},{"date":"2023-09-01","current":-5.345867,"twenty":-10.753062,"median":-5.981578,"eighty":-1.628804,"marketCap":5316428769},{"date":"2023-09-08","current":-5.280752,"twenty":-10.708668,"median":-5.97485,"eighty":-1.636204,"marketCap":5189847132},{"date":"2023-09-15","current":-5.170409,"twenty":-10.661904,"median":-5.926032,"eighty":-1.639938,"marketCap":5120802603},{"date":"2023-09-22","current":-5.368163,"twenty":-10.635116,"median":-5.914502,"eighty":-1.646947,"marketCap":5293413926},{"date":"2023-09-29","current":-4.858025,"twenty":-10.624505,"median":-5.883829,"eighty":-1.661322,"marketCap":4798594798},{"date":"2023-10-06","current":-4.848749,"twenty":-10.61454,"median":-5.773557,"eighty":-1.668023,"marketCap":4787139493},{"date":"2023-10-13","current":-5.562225,"twenty":-10.564028,"median":-5.739914,"eighty":-1.675856,"marketCap":5483346078},{"date":"2023-10-20","current":-5.407133,"twenty":-10.491544,"median":-5.685854,"eighty":-1.689017,"marketCap":5322240422},{"date":"2023-10-27","current":-5.848058,"twenty":-10.464228,"median":-5.638197,"eighty":-1.692848,"marketCap":5753773430},{"date":"2023-11-03","current":-6.149851,"twenty":-10.451382,"median":-5.711436,"eighty":-1.699726,"marketCap":6066766557},{"date":"2023-11-10","current":-6.384576,"twenty":-10.4304,"median":-5.764995,"eighty":-1.706296,"marketCap":6297004377},{"date":"2023-11-17","current":-6.639835,"twenty":-10.408468,"median":-5.848058,"eighty":-1.718791,"marketCap":6607825434},{"date":"2023-11-24","current":-6.493833,"twenty":-10.378473,"median":-5.907382,"eighty":-1.726122,"marketCap":6515730306},{"date":"2023-12-01","current":-5.273334,"twenty":-10.37221,"median":-5.903555,"eighty":-1.746019,"marketCap":5313056131},{"date":"2023-12-08","current":-5.174269,"twenty":-10.330292,"median":-5.814243,"eighty":-1.75364,"marketCap":5192174031},{"date":"2023-12-15","current":-3.798534,"twenty":-10.253372,"median":-5.763304,"eighty":-1.761472,"marketCap":3833689473},{"date":"2023-12-22","current":-3.418682,"twenty":-10.23016,"median":-5.700611,"eighty":-1.768418,"marketCap":3448018009},{"date":"2023-12-29","current":-3.690081,"twenty":-10.222257,"median":-5.681922,"eighty":-1.769516,"marketCap":3741588825},{"date":"2024-01-05","current":-3.436204,"twenty":-10.217047,"median":-5.591562,"eighty":-1.775076,"marketCap":3459596526},{"date":"2024-01-12","current":-3.457234,"twenty":-10.205563,"median":-5.536622,"eighty":-1.784852,"marketCap":3482622127},{"date":"2024-01-19","current":-3.16443,"twenty":-10.190983,"median":-5.505597,"eighty":-1.807794,"marketCap":3183289316},{"date":"2024-01-26","current":-2.65403,"twenty":-10.173418,"median":-5.476058,"eighty":-1.821423,"marketCap":2659456897},{"date":"2024-02-02","current":-2.249035,"twenty":-10.089285,"median":-5.426105,"eighty":-1.824513,"marketCap":2250760075},{"date":"2024-02-09","current":-2.587166,"twenty":-10.030435,"median":-5.409235,"eighty":-1.829896,"marketCap":2601901672},{"date":"2024-02-16","current":-2.809787,"twenty":-10.022591,"median":-5.397864,"eighty":-1.834109,"marketCap":2826402038},{"date":"2024-02-23","current":-3.595568,"twenty":-10.01212,"median":-5.379088,"eighty":-1.841383,"marketCap":3597762268},{"date":"2024-03-01","current":-3.806058,"twenty":-10.006005,"median":-5.366225,"eighty":-1.846553,"marketCap":3810756223},{"date":"2024-03-08","current":-3.517028,"twenty":-9.991673,"median":-5.353274,"eighty":-1.858357,"marketCap":3522934756},{"date":"2024-03-15","current":-3.669692,"twenty":-9.971476,"median":-5.345687,"eighty":-1.864552,"marketCap":3672601918},{"date":"2024-03-22","current":-3.454281,"twenty":-9.939836,"median":-5.324793,"eighty":-1.870298,"marketCap":3453857604},{"date":"2024-03-28","current":-4.293587,"twenty":-9.863568,"median":-5.283345,"eighty":-1.873457,"marketCap":3476883321},{"date":"2024-04-05","current":-4.296416,"twenty":-9.859679,"median":-5.278537,"eighty":-1.897232,"marketCap":3476883321},{"date":"2024-04-12","current":-4.06649,"twenty":-9.842403,"median":-5.265351,"eighty":-1.914383,"marketCap":3292683193},{"date":"2024-04-19","current":-3.201894,"twenty":-9.830267,"median":-5.246113,"eighty":-1.930756,"marketCap":2590397617},{"date":"2024-04-26","current":-3.882637,"twenty":-9.828164,"median":-5.227283,"eighty":-1.960452,"marketCap":3137259336},{"date":"2024-05-03","current":-4.412872,"twenty":-9.822644,"median":-5.190892,"eighty":-1.980559,"marketCap":3563235833},{"date":"2024-05-10","current":-4.388196,"twenty":-9.799273,"median":-5.172187,"eighty":-2.059596,"marketCap":3551722955},{"date":"2024-05-17","current":-4.665305,"twenty":-9.769071,"median":-5.13976,"eighty":-2.176027,"marketCap":3770467643},{"date":"2024-05-24","current":-4.768789,"twenty":-9.741505,"median":-5.06514,"eighty":-2.235661,"marketCap":3845301352},{"date":"2024-05-31","current":-4.899442,"twenty":-9.731744,"median":-5.028419,"eighty":-2.249727,"marketCap":3954673696},{"date":"2024-06-07","current":-4.27374,"twenty":-9.695026,"median":-5.010041,"eighty":-2.252748,"marketCap":3445348655},{"date":"2024-06-14","current":-4.391089,"twenty":-9.670514,"median":-4.9885,"eighty":-2.253757,"marketCap":3536708036},{"date":"2024-06-21","current":-3.957414,"twenty":-9.669207,"median":-4.858025,"eighty":-2.27113,"marketCap":3180740669},{"date":"2024-06-28","current":-3.416267,"twenty":-9.656329,"median":-4.848456,"eighty":-2.271193,"marketCap":2744658792},{"date":"2024-07-05","current":-3.116409,"twenty":-9.644569,"median":-4.823842,"eighty":-2.288955,"marketCap":2503206857},{"date":"2024-07-12","current":-3.048649,"twenty":-9.640541,"median":-4.794904,"eighty":-2.314498,"marketCap":2452377267},{"date":"2024-07-19","current":-3.241813,"twenty":-9.626631,"median":-4.759394,"eighty":-2.33858,"marketCap":2607809629},{"date":"2024-07-26","current":-2.96601,"twenty":-9.621662,"median":-4.747373,"eighty":-2.37201,"marketCap":2394809726},{"date":"2024-08-02","current":-2.789389,"twenty":-9.613456,"median":-4.667015,"eighty":-2.39703,"marketCap":2250890872},{"date":"2024-08-09","current":-2.772124,"twenty":-9.574791,"median":-4.652795,"eighty":-2.403112,"marketCap":2251867265},{"date":"2024-08-16","current":-2.862478,"twenty":-9.552947,"median":-4.531542,"eighty":-2.424708,"marketCap":2326167454},{"date":"2024-08-23","current":-2.5913,"twenty":-9.491495,"median":-4.424353,"eighty":-2.446312,"marketCap":2114697685},{"date":"2024-08-30","current":-2.433132,"twenty":-9.396193,"median":-4.410397,"eighty":-2.432506,"marketCap":1857504723},{"date":"2024-09-06","current":-2.012915,"twenty":-9.371833,"median":-4.407267,"eighty":-2.384786,"marketCap":1537442371},{"date":"2024-09-13","current":-2.34081,"twenty":-9.36333,"median":-4.390474,"eighty":-2.314498,"marketCap":1783204534},{"date":"2024-09-20","current":-2.282109,"twenty":-9.359966,"median":-4.387939,"eighty":-2.289347,"marketCap":1748912139},{"date":"2024-09-27","current":-3.172887,"twenty":-9.315256,"median":-4.349275,"eighty":-2.289347,"marketCap":2446190836},{"date":"2024-10-04","current":-3.522485,"twenty":-9.280278,"median":-4.336648,"eighty":-2.294847,"marketCap":2703383797},{"date":"2024-10-10","current":-3.419324,"twenty":-9.25963,"median":-4.323569,"eighty":-2.300216,"marketCap":2607219971},{"date":"2024-10-18","current":-2.901761,"twenty":-9.198146,"median":-4.295001,"eighty":-2.314342,"marketCap":2201042544},{"date":"2024-10-25","current":-3.003259,"twenty":-9.141589,"median":-4.274413,"eighty":-2.323828,"marketCap":2277886922},{"date":"2024-11-01","current":-3.464077,"twenty":-9.136448,"median":-4.265022,"eighty":-2.340197,"marketCap":2629175507},{"date":"2024-11-08","current":-5.509053,"twenty":-9.10619,"median":-4.260606,"eighty":-2.341304,"marketCap":4149596417},{"date":"2024-11-15","current":-4.478987,"twenty":-8.973808,"median":-4.274076,"eighty":-2.350464,"marketCap":3348219331},{"date":"2024-11-22","current":-5.156949,"twenty":-8.806878,"median":-4.293587,"eighty":-2.380591,"marketCap":3853196673},{"date":"2024-11-29","current":-4.888422,"twenty":-8.7186,"median":-4.321083,"eighty":-2.389246,"marketCap":3650107959},{"date":"2024-12-06","current":-5.106278,"twenty":-8.679179,"median":-4.336648,"eighty":-2.401895,"marketCap":3803796715},{"date":"2024-12-13","current":-7.146685,"twenty":-8.563165,"median":-4.35718,"eighty":-2.408816,"marketCap":5313239857},{"date":"2024-12-20","current":-6.244103,"twenty":-8.379524,"median":-4.388196,"eighty":-2.430631,"marketCap":4621640454},{"date":"2024-12-27","current":-6.226686,"twenty":-8.355644,"median":-4.390474,"eighty":-2.432507,"marketCap":4605173801},{"date":"2025-01-03","current":-7.139968,"twenty":-8.299043,"median":-4.402961,"eighty":-2.443486,"marketCap":5285795436},{"date":"2025-01-10","current":-6.88431,"twenty":-8.223849,"median":-4.407922,"eighty":-2.477657,"marketCap":5077217838},{"date":"2025-01-17","current":-7.629845,"twenty":-8.182771,"median":-4.420646,"eighty":-2.498821,"marketCap":5631595137},{"date":"2025-01-24","current":-7.597114,"twenty":-8.182771,"median":-4.478987,"eighty":-2.502283,"marketCap":5642572906},{"date":"2025-01-28","current":-7.410475,"twenty":-8.174393,"median":-4.50623,"eighty":-2.503264,"marketCap":5532795223},{"date":"2025-02-07","current":-6.905522,"twenty":-8.129174,"median":-4.573822,"eighty":-2.50642,"marketCap":5126617796},{"date":"2025-02-14","current":-7.544999,"twenty":-8.122982,"median":-4.652795,"eighty":-2.520444,"marketCap":5598661833},{"date":"2025-02-21","current":-9.434583,"twenty":-8.198204,"median":-4.667015,"eighty":-2.522105,"marketCap":7025771712},{"date":"2025-02-28","current":-11.802643,"twenty":-8.387484,"median":-4.740857,"eighty":-2.531102,"marketCap":8760259103},{"date":"2025-03-07","current":-11.8291,"twenty":-8.82761,"median":-4.749818,"eighty":-2.53167,"marketCap":8815147944},{"date":"2025-03-14","current":-9.365593,"twenty":-9.14248,"median":-4.791751,"eighty":-2.532953,"marketCap":6981860638},{"date":"2025-03-21","current":-8.003288,"twenty":-9.184856,"median":-4.800314,"eighty":-2.534267,"marketCap":6850127419},{"date":"2025-03-28","current":-10.15866,"twenty":-9.193009,"median":-4.826251,"eighty":-2.537422,"marketCap":8677346303},{"date":"2025-04-03","current":-9.469219,"twenty":-9.300685,"median":-4.848749,"eighty":-2.539639,"marketCap":8072461580},{"date":"2025-04-11","current":-7.909154,"twenty":-9.274441,"median":-4.873223,"eighty":-2.576728,"marketCap":6697723572},{"date":"2025-04-17","current":-8.252995,"twenty":-9.235847,"median":-4.894545,"eighty":-2.58622,"marketCap":7005664886},{"date":"2025-04-25","current":-9.96754,"twenty":-9.360466,"median":-4.944659,"eighty":-2.586741,"marketCap":8468386126},{"date":"2025-05-02","current":-10.304543,"twenty":-9.374966,"median":-4.9885,"eighty":-2.587993,"marketCap":8773311140},{"date":"2025-05-09","current":-10.836143,"twenty":-9.469219,"median":-4.996395,"eighty":-2.5913,"marketCap":9290683315}],"updateTime":1747040305726}}}